Search and Filter
Results per Page:
Fred Hutch leads new Vanguard Study for Cancer Screening Research Network
Study aims to understand the effectiveness and use of multi-cancer detection blood tests
After a locoregional recurrence, a breast cancer patient sought out expert care at Fred Hutch
Her care team recommended protons because of her previous radiation exposure
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
How do you measure your health? WHI comes up with two potent indicators
New studies using Women’s Health Initiative data highlight new ‘biomarkers’ to predict mortality risk and guide providers' care
AI technology is making charting less time-consuming
Fred Hutch and UW are part of a pilot program testing Abridge ‘ambient listening’ tool
Mapping molecules of an unsung brain cell
Fred Hutch researchers create a gene-expression map of glial cells in tiny worms, adding the missing component that completes for the first time an atlas of the entire nervous system of a multicellular adult animal at the molecular level
When donors go all in, the magic begins
Aldarra Foundation achieved maximum impact at Fred Hutch and beyond by giving boldly, with purpose and on a timeline
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Fred Hutch names Board of Directors' leadership, adds new board member
Current board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors
Fred Hutch is one of the only centers in the region offering oral medicine services
Specialized oral care for cancer patients is part of multidisciplinary care
Surgery, proton therapy and chemotherapy saved a 2-year-old patient from a rare brain cancer
Proton therapy was ‘the easy part of the ballgame’ for treating a rare pediatric cancer
The Beam: Proton therapy for sarcomas; radiation oncology residency program
Can proton therapy benefit sarcoma patients? What are residencies, and why are they important in health care?
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease
Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a biological mechanism that could lead to new therapies
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award
National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
TakePART-NW, an ambitious new precision oncology research program, launches at Fred Hutch
Patients who opt in may help solve the mysteries of cancer and other diseases
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career researchers to each receive $50,000 toward innovative cancer research projects